glp-1 receptor agonist atrial fibrillation risk Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms of action GLP‑1 Therapy Improves Atrial Fibrillation
Description
RCT SCALE Study - Liraglutide vs Placebo for Weight Loss in Overweight Nondiabetic Adults, NEJM (2015) [PubMed abstract] The SCALE study enrolled 3731 overweight adults who did not have diabetes Main inclusion criteria BMI 30
10.1093/eurheartj/ehae508 88
Diabetes 53 , 654662 (2004)
In addition, GLP-1 RAs were not associated with increased risk of suicide death, self-harm, or incident depression and anxiety-related disorders
Moretto et al., 2008
Pectin stimulates GLP-1 secretion in the isolated perfused rat colon [304] but not in the isolated rat ileum [250]
